NCT00481702View on ClinicalTrials.gov

A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
Intra-abdominal Infection
Interventions
DRUG

Comparator: ceftriaxone sodium / Duration of Treatment: 8 Weeks

DRUG

MK0826, /Duration of Treatment : 8 Weeks

DRUG

Comparator: metronidazole / Duration of Treatment: 8 Weeks

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00481702 - A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802) | Biotech Hunter | Biotech Hunter